NAV & Valuation Reporting
Independent, transparent valuation for illiquid insurance assets.
Robust valuation for Lloyd’s participations.
Hedge funds and ILS managers increasingly use Lloyd’s participations to access uncorrelated risk. However, the lag in Lloyd’s financial reporting (often 4+ weeks) creates a significant challenge for regular NAV reporting.
ICMR bridges this gap.
We provide independent, “mark-to-model” estimates of Net Asset Value (NAV) for syndicate portfolios, allowing funds to meet regulatory requirements and investor transparency standards with confidence.
The Challenge
Lloyd’s financial statements are infrequent. By the time quarterly data is released, it is often 4 - 6 weeks out of date.
The Solution
ICMR has developed a transparent methodology to meet your NAV reporting timelines, e.g. last business day of the month.
Price-to-Book Monitoring
Real-time Industry Valuation
ICMR provides an “outside-in” perspective on the valuation multiples of Lloyd’s syndicates and managing agencies.
Leveraging our RISX Index database—which tracks the daily pricing of global specialty (re)insurers—we maintain a comprehensive model of trailing book values and market multiples.
- M&A Timing: Identify optimal windows for acquisitions or exits.
- Benchmarking: Compare your internal valuation against public market peers.
- Strategic Planning: Set realistic targets for corporate value creation.
Distribution of trailing price-to-book multiples as of March of each year, following the release of the annual financial statements.
Relating this price to book value information to Lloyd’s syndicates reveals the following hypothetical valuations of individual syndicates. (NB - this assumes every syndicate is a discrete integrated Lloyd’s vehicle (ILV) with no capital diversification benefit between syndicates; it is based on ICMR outside-in modelling of every syndicate’s ECA requirement).
ICMR estimate of syndicate price to book (ECA) valuation as of 31 March 2026. All ECA numbers are estimated by ICMR as if for whole syndicates; no account taken of member level capital.
Powered by RISX
The RISX Index constituent companies form the first true equity benchmark for the global specialty sector.
We extract daily pricing data from global exchanges to derive the sector’s “Cost of Equity” and valuation trends.
Visit RISXindex.com
Need independent valuation support?
Contact us to discuss your specific reporting requirements.


